Responsiveness of the Self-Administered Foot Evaluation Questionnaire (SAFE-Q) in patients with hallux valgus

J Orthop Sci. 2017 Jul;22(4):737-742. doi: 10.1016/j.jos.2017.04.005. Epub 2017 May 10.

Abstract

Background: In this study, we investigated the responsiveness of the Self-Administered Foot Evaluation Questionnaire (SAFE-Q) for patient's assessment before and after hallux valgus surgery.

Methods: Patient-reported answers on the SAFE-Q and Short Form-36 (SF-36) before and at a mean of 3-4 and 9-12 months after hallux valgus surgery were analyzed. Data of 100 patients (92 women, eight men) from 36 institutions throughout Japan were used for analysis.

Results: In all subscales of the SAFE-Q, the trend of increased scores after surgery was statistically significant (P < 0.001). Among the patients with available scores both before and at 9-12 months after surgery (n = 66), the largest effect sizes (ESs) were observed for shoe-related (1.60), pain and pain-related (1.05), and general health and well-being (0.84) scales. In the SF-36 (n = 64), the largest ES was observed for the bodily pain scale (0.86). Less notable changes were observed for the remaining SF-36 domains.

Conclusion: The SAFE-Q is the first patient-reported outcome measure which includes a quality of life assessment of shoes. In our cohort, the most remarkable responsiveness was observed for the shoe-related subscale. Based on its responsiveness, the SAFE-Q appears to be sufficient for evaluation of foot-related quality of life before and after surgery.

MeSH terms

  • Activities of Daily Living
  • Cohort Studies
  • Female
  • Hallux Valgus / complications
  • Hallux Valgus / surgery*
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Pain / diagnosis
  • Pain / etiology
  • Pain / surgery
  • Pain Measurement
  • Patient Outcome Assessment
  • Reproducibility of Results
  • Self Report*